| An integrated understanding of the rapid metabolic benefits of a carbohydrate-restricted diet on hepatic steatosis in humans A Mardinoglu, H Wu, E Bjornson, C Zhang, A Hakkarainen, SM Räsänen, ... Cell metabolism 27 (3), 559-571. e5, 2018 | 412 | 2018 |
| Prevalence of subclinical coronary artery atherosclerosis in the general population G Bergström, M Persson, M Adiels, E Björnson, C Bonander, H Ahlström, ... Circulation 144 (12), 916-929, 2021 | 228 | 2021 |
| Personal model‐assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD A Mardinoglu, E Bjornson, C Zhang, M Klevstig, S Söderlund, M Ståhlman, ... Molecular systems biology 13 (3), 916, 2017 | 165 | 2017 |
| Integrated network analysis reveals an association between plasma mannose levels and insulin resistance S Lee, C Zhang, M Kilicarslan, BD Piening, E Bjornson, BM Hallström, ... Cell metabolism 24 (1), 172-184, 2016 | 155 | 2016 |
| Stratification of hepatocellular carcinoma patients based on acetate utilization E Björnson, B Mukhopadhyay, A Asplund, N Pristovsek, R Cinar, ... Cell reports 13 (9), 2014-2026, 2015 | 137 | 2015 |
| Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity MR Taskinen, S Söderlund, LH Bogl, A Hakkarainen, N Matikainen, ... Journal of internal medicine 282 (2), 187-201, 2017 | 129 | 2017 |
| Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: a single‐Centre randomized … N Matikainen, S Söderlund, E Björnson, K Pietiläinen, A Hakkarainen, ... Diabetes, obesity and metabolism 21 (1), 84-94, 2019 | 101 | 2019 |
| Kinetics of plasma triglycerides in abdominal obesity E Björnson, M Adiels, MR Taskinen, J Borén Current opinion in lipidology 28 (1), 11-18, 2017 | 100 | 2017 |
| Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia J Boren, MR Taskinen, E Björnson, CJ Packard Nature Reviews Cardiology 19 (9), 577-592, 2022 | 98 | 2022 |
| Extensive weight loss reveals distinct gene expression changes in human subcutaneous and visceral adipose tissue A Mardinoglu, JT Heiker, D Gärtner, E Björnson, MR Schön, G Flehmig, ... Scientific reports 5 (1), 14841, 2015 | 69 | 2015 |
| Personalized cardiovascular disease prediction and treatment—a review of existing strategies and novel systems medicine tools E Björnson, J Borén, A Mardinoglu Frontiers in Physiology 7, 2, 2016 | 59 | 2016 |
| Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans J Borén, M Adiels, E Björnson, N Matikainen, S Söderlund, J Rämö, ... JCI insight 5 (24), 2020 | 54 | 2020 |
| Role of apolipoprotein C‐III overproduction in diabetic dyslipidaemia M Adiels, MR Taskinen, E Björnson, L Andersson, N Matikainen, ... Diabetes, obesity and metabolism 21 (8), 1861-1870, 2019 | 48 | 2019 |
| Investigation of human apoB48 metabolism using a new, integrated non‐steady‐state model of apoB48 and apoB100 kinetics E Björnson, CJ Packard, M Adiels, L Andersson, N Matikainen, ... Journal of internal medicine 285 (5), 562-577, 2019 | 48 | 2019 |
| Characterization of different fat depots in NAFLD using inflammation-associated proteome, lipidome and metabolome A Lovric, M Granér, E Bjornson, M Arif, R Benfeitas, K Nyman, M Ståhlman, ... Scientific reports 8 (1), 14200, 2018 | 43 | 2018 |
| Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study E Björnson, M Adiels, MR Taskinen, S Burgess, A Rawshani, J Borén, ... European Heart Journal 44 (39), 4186-4195, 2023 | 38 | 2023 |
| Complex I is bypassed during high intensity exercise A Nilsson, E Björnson, M Flockhart, FJ Larsen, J Nielsen Nature communications 10 (1), 5072, 2019 | 38 | 2019 |
| Apolipoprotein B48 metabolism in chylomicrons and very low‐density lipoproteins and its role in triglyceride transport in normo‐and hypertriglyceridemic human subjects E Björnson, CJ Packard, M Adiels, L Andersson, N Matikainen, ... Journal of internal medicine 288 (4), 422-438, 2020 | 37 | 2020 |
| The acute effect of metabolic cofactor supplementation: a potential therapeutic strategy against non‐alcoholic fatty liver disease C Zhang, E Bjornson, M Arif, A Tebani, A Lovric, R Benfeitas, M Ozcan, ... Molecular systems biology 16 (4), e9495, 2020 | 37 | 2020 |
| Effects of liraglutide on the metabolism of triglyceride‐rich lipoproteins in type 2 diabetes MR Taskinen, E Björnson, N Matikainen, S Söderlund, KH Pietiläinen, ... Diabetes, Obesity and Metabolism 23 (5), 1191-1201, 2021 | 28 | 2021 |
